Centre of excellence in India
Agilent Technologies has expanded its Life Sciences and Chemical Analysis Centre of Excellence in Bangalore, India.
Agilent Technologies has expanded its Life Sciences and Chemical Analysis Centre of Excellence in Bangalore, India. The company also has opened a Life Science application development lab, in an adjacent facility, to accelerate the discovery of life science analysis workflows. Together, the centre and lab cover 8000 square feet, making this the largest Agilent research facility in the world.
"India continues to be one of the most important markets for Agilent globally, with a significant presence of high-end R&D in pharmaceuticals and biotechnology," said Parmeet Ahuja, country general manager, Agilent Technologies, India. "This is the first Agilent lab facility where development of application solutions, customer interactions and training will happen in parallel."
Originally opened in 2006, the Bangalore centre serves the company’s customers across India. Customers now have access to Agilent's newest high-end products, including the 7700 Series ICP-MS, 7000B GC-QQQ, 6490 QQQ, 6540 QTOF and the 1290 and 1260 Infinity LC. Additionally, all of the company’s core products, including gas chromatographs, liquid chromatographs, electrophoresis and genomics products, and mass spectrometry systems are available for use.
The combined facility plays an important role in applications and solutions development, as well as in customer education. The company’s application scientists engaged in pharma, biopharma and other life science applications staff the facility and work hand in hand with customers, thereby having access to critical samples and learning about emerging application needs.
For more information on the facility visit www.agilent.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
